M. N. V. Ravi Kumar

Education

• PhD (Drug delivery, Nov 26, 2000), Indian Institute of Technology (Formerly, University of) Roorkee, India

• MSc (1996), Devi Ahilya Vishwa Vidyalaya, Indore

• BSc (1992), Nagarjuna University, Andhra Pradesh

Awards/Scholarships/Other Recognition

• 2008 Tom Gibson Memorial Award from the British Society of Plastic Surgeons, the Royal College of Physicians and Surgeons Glasgow.

• 2007 Indian National Science Academy (INSA) Medal for Young Scientist

• 2002 Alexander von Humboldt Research Fellowship, Germany

Patents

• M. N. V. Ravi Kumar, D. D. Ankola, V. Bhoomi, V. Bhardwaj and P. Ramarao, Nanoparticulate formulation of Coenzyme Q10.  18/Del/2006

• M. N. V. Ravi Kumar, N. Kashyap, V. Bhoomi, V. Bhardwaj, P. Ramarao and N. Kumar, Design of glucose sensitive in situ gelling system based on chitosan for pulsatile delivery of insulin. 36/del/2006

• M. N. V. Ravi Kumar, D. Venkat Ratnam, Kiran Sonaje, V. Bhoomi, V. Bhardwaj and P. Ramarao, Nano-co-encapsulated antioxidant particles (NanoCAPs). 1691/del/2006

• M. N. V. Ravi Kumar, J. L. Italia, D. Bhatt , V. Bhardwaj and K. B. Tikoo, Nanoparticles containing cyclosporine. 1690/del/2006

• M. N. V. Ravi Kumar, V. Bhardwaj and D. D. Ankola, Polymeric nanoparticles of paclitaxel for treatment of cancers. 2636/del/2006

Publications ~70

Select Publications

• G. Mittal, G. Chandraiah, P. Ramarao and M.N.V. Ravi Kumar. Pharmacodynamic evaluation of oral estradiol nanoparticles in estrogen deficient (ovariectomized) high-fat diet induced hyperlipidemic female rat model. Pharmaceutical Research (In Press)

• J. Schafer, J. Sitterberg, C. Ehrhardt, M. N. V. Ravi Kumar and U. Bakowsky, A new drug vehicle-Lipid coated biodegradable nanoparticles, Advances in Science and Technology, 57 (2008) 148-153.

• J. L. Italia, P. Datta, D.D. Ankola and M. N. V. Ravi Kumar, Nanoparticles enhance per oral bioavailability of poorly available molecules: Epigallocatechin gallate nanoparticles ameliorates cyclosporine induced nephrotoxicity in rats at three times lower dose than oral suspension. Journal of Biomedical Nanotechnology 4 (2008) 304-312.

• D. Sahana, G. Mittal, V. Bhardwaj and M. N. V. Ravi Kumar PLGA Nanoparticles for Oral Administration of hydrophobic drugs: Influence of organic solvent on nanoparticle formation and release behavior in vitro and in vivo using estradiol as a model drug Journal of Pharmaceutical Sciences, 97 (2008) 1530-1542.

• A. K. Meena, D. Venkat Ratnam, G. Chandraiah, D.D. Ankola, P. Rama Rao and M.N.V. Ravi Kumar, Oral nanoparticulate atorvastatin calcium is more efficient and safe in comparison to Lipicure® in treating hyperlipidemia, Lipids 43 (2008) 231-241.

• D. Venkat Ratnam, G. Chandraiah, K. Sonaje, B. Viswanad, V. Bhardwaj, P. Rama Rao and M.N.V. Ravi Kumar, A potential therapeutic strategy for diabetes and its complications in the form of co-encapsulated antioxidant nanoparticles (NanoCAPs) of ellagic acid and coenzyme Q10: Preparation and evaluation in streptozotocin induced diabetic rats Journal of Biomedical Nanotechnology  4 (2008) 33-43.

Conference Presentations ~50

Professional Activities

• Editor-in-chief, Journal of Biomedical Nanotechnology

• Member, Editorial board, Recent Patents on Material Sciences

• Member, Editorial board, Journal of Nanoscience and Nanotechnology

• Member, Editorial board, The Open drug delivery Journal

• Member, Editorial board, The Open Nanomedicine Journal

Seminars Delivered ~40

Back to Group